NEW YORK (GenomeWeb) – Agilent Technologies announced today that it is extending a longstanding agreement with PerkinElmer to continue the supply of chips for Agilent's 2100 Bioanalyzer system.

The terms of the deal extension were not disclosed.

The 2100 Bioanalyzer, which was first introduced in 1999, is used in DNA sequencing, gene expression research, DNA fragment analysis, and quality control for protein-based drugs, among other applications, according to Agilent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.